Fell Valentin H K, Kramer Tim, Heindl Andreas, Merkel Olivia M
Department of Pharmacy, Pharmaceutical Technology and Biopharmaceutics, Ludwig-Maximilians-Universität München, Butenandtstr. 5-13, Munich 81377, Germany.
CordenPharma International GmbH, Branch Frankfurt, Alt-Fechenheim 34, Building C26, Frankfurt am Main 60386, Germany.
ACS Mater Au. 2025 Feb 27;5(3):451-457. doi: 10.1021/acsmaterialsau.4c00158. eCollection 2025 May 14.
One of the most important parameters for the development of novel ionizable lipids (ILs) for use in lipid nanoparticle (LNP) drug carriers is their p value. Ideally, the LNP should be deprotonated outside the cell to prevent cytotoxicity and protonated inside the endosome, where pH is lower. To achieve this switch, the LNP's p value, the so-called "apparent p value", should range generally between 5.5 and 7. For specific applications, the range is narrower. We present a straightforward approach to computationally estimate this apparent p value of LNPs using density functional theory (DFT). This method uses "surrogates" of the ILs, which are hypothetical derivatives featuring an ,-dimethylethylaminium side group attached to the lipid's nitrogen atom.
用于脂质纳米颗粒(LNP)药物载体的新型可电离脂质(IL)开发的最重要参数之一是其pKa值。理想情况下,LNP应在细胞外去质子化以防止细胞毒性,并在内体(pH值较低)内质子化。为实现这种转变,LNP的pKa值,即所谓的“表观pKa值”,通常应在5.5至7之间。对于特定应用,该范围更窄。我们提出了一种使用密度泛函理论(DFT)通过计算估计LNP的这种表观pKa值的直接方法。该方法使用IL的“替代物”,这些替代物是具有连接到脂质氮原子上的α,α-二甲基乙铵侧基的假想衍生物。